CHPA Statement: FDA Warning Regarding Reports of Teen Abuse of Diphenhydramine
September 26, 2020
September 26, 2020
WASHINGTON, Sept. 26 (TNSRes) -- The Consumer Healthcare Products Association issued the following statement:
* * *
"The Consumer Healthcare Products Association (CHPA) shares FDA's concern regarding news reports that teens are challenging each other on social media to misuse and abuse over-the-counter (OTC) medicines containing diphenhydramine, commonly used for allergy symptoms. CHPA applauds FDA for examining this issue more closely as data will play a critical . . .
* * *
"The Consumer Healthcare Products Association (CHPA) shares FDA's concern regarding news reports that teens are challenging each other on social media to misuse and abuse over-the-counter (OTC) medicines containing diphenhydramine, commonly used for allergy symptoms. CHPA applauds FDA for examining this issue more closely as data will play a critical . . .